Social Media Ideas for Tpyrx

TCW Private Asset Income Fund Q2 2026 Commentary

Eli Lilly-backed TRex Bio closes day flat after IPO

<![CDATA[Roundup: TRexBio & Retension Pharmaceuticals Announce IPO Pricing ]]>

Tenpoint

Tenpoint Anonymous (not verified) Sun, 10/18/2026 - 10:14 field_thread_url https://cafepharma.com/boards/threads/tenpoint.711562/ board...

Tenpoint

Tenpoint Anonymous (not verified) Sat, 10/17/2026 - 10:13 field_thread_url https://cafepharma.com/boards/threads/tenpoint.711562/ board...

Tyra Biosciences: 'Hold' IR-NMIBC Data September 9th 2026, With Caution Ahead For 2027 Readouts

Some GLP-1 injections recalled due to 'lack of assurance of sterility'

Apothecary Pharma, a compounding pharmacy, voluntarily recalled 22 vials of Tirzepatide injections due to a "lack of assurance of sterility," according to the official announcement...

CareTria Launches RYALTRIS® Direct, Expanding Patient Access Through Pharmacy, Telesales, and Sampling Support

New offering creates a connected path from product sample to prescription fulfilment, helping simplify access to RYALTRIS® for providers and patients LAKEWOOD, N.J., Sept. 17, 202...

Terumo Corporation (TRUMY) Arsenal Medical, Inc. - M&A Call - Slideshow

Touchstone Sands Capital International Growth Equity Fund Q2 2026 Commentary

PearlMatrix® P-15 Peptide Enhanced Bone Graft Receives Medicare New Technology Add-on Payment (NTAP), Helping Hospitals...

NTAP provides additional Medicare reimbursement to hospitals using PearlMatrix, the first and only bone growth accelerator demonstrating superior lumbar fusion speed.

Oramed Pharmaceuticals: Hold Reiterated As Alpha Tau Investment Delivers And More

TRex Bio prices $117M IPO to support immune drug work

Eli Lilly is the largest equity holder in TRex, which is developing drugs that treat immunological conditions by activating “Treg” cells.

BioXcel files for Chapter 11, will sell assets to Teva

GLP-1 Injections Recalled Nationwide. See Affected Products

Twenty-two vials of compounded tirzepatide are affected, and the pharmacy had an FDA warning letter on sterility problems before the recall.

TRrexBio’s IPO Bags $116M to Bring the Immune System Back Into Balance

Eli Lilly-partnered TRexBio will apply the IPO proceeds toward clinical development of molecules designed to activate regulatory T cells to mediate immune responses and inflammatio...

TRexBio prices $117M IPO at $14 per share

Better Pharma ETF: iShares IHE vs. State Street XPH

IHE concentrates 23.6% in Eli Lilly and delivers 1.4% yield, while XPH spreads risk across 62 holdings with a lower 0.35% expense ratio.

Rhythm Pharma

Rhythm Pharma Anonymous (not verified) Tue, 10/06/2026 - 04:08 field_thread_url https://cafepharma.com/boards/threads/rhythm-pharma.674576/...

Royalty Pharma plc (RPRX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Rhythm Pharma

Rhythm Pharma Anonymous (not verified) Mon, 09/28/2026 - 01:03 field_thread_url https://cafepharma.com/boards/threads/rhythm-pharma.674576/...

Personify Health Introduces Transform+ to Help Employers Manage GLP-1 Costs and Improve Cardiometabolic Outcomes

Developed in collaboration with 9amHealth, the new offering gives employers flexible strategies to deliver and manage specialty cardiometabolic care across their organizations TEMP...

EPtalk by Dr. Jayne 10/22/26

I was excited to see Epic’s announcement about its Prescription Marketplace feature. It allows patients to compare pharmacy prices before they leave the physician’s office. The dev...

TLC590 Achieves Statistically Significant Reductions in Pain and Opioid Use Versus Both Placebo and Liposomal Bupivacain...

TLC BioSciences Corp. today announced positive topline results from its pivotal Phase 3 trial of TLC590.